Invasive Fusariosis: A Single Pediatric Center 15-Year Experience.

Invasive fungal infection (IFI) is an important cause of mortality in immunocompromised children, particularly after hematopoietic stem cell transplantation. We describe 5 cases of Fusarium IFI in immunocompromised children seen at our institution over a 15-year period. A summary of all published pediatric cases of invasive Fusarium infection is presented. A focus on antifungal management challenges in these patients will be discussed.

[1]  C. Baker,et al.  Red book®: 2003 report of the committee on infectious diseases. , 2016 .

[2]  S. Botton,et al.  Synergysm of voriconazole or itraconazole with other antifungal agents against species of Fusarium. , 2013, Revista iberoamericana de micologia.

[3]  W. Shi,et al.  Fusarium Keratitis: Genotyping, In Vitro Susceptibility and Clinical Outcomes , 2013, Cornea.

[4]  T. Egberts,et al.  Highly Variable Plasma Concentrations of Voriconazole in Pediatric Hematopoietic Stem Cell Transplantation Patients , 2012, Antimicrobial Agents and Chemotherapy.

[5]  C. Rongkavilit,et al.  A knee ulcer in a teenager with acute myeloid leukemia. , 2012, The Pediatric infectious disease journal.

[6]  Recommended Doses of Parenteral and Oral Antifungal Drugs , 2012, Red Book (2015).

[7]  D. Kontoyiannis,et al.  Invasive Mold Infections in Pediatric Cancer Patients Reflect Heterogeneity in Etiology, Presentation, and Outcome: A 10-Year, Single-Institution, Retrospective Study. , 2012, Journal of the Pediatric Infectious Diseases Society.

[8]  A. Lozniewski,et al.  Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[9]  D. Colantonio,et al.  Therapeutic Drug Monitoring of Voriconazole in Children , 2012, Therapeutic drug monitoring.

[10]  E. Mylonakis,et al.  The challenge of managing fusariosis , 2011, Virulence.

[11]  S. H. Alves,et al.  In vitro interactions between amphotericin B and other antifungal agents and rifampin against Fusarium spp. , 2011, Mycoses.

[12]  S. Hmida,et al.  Successful treatment of fusarium solani ecthyma gangrenosum in a patient affected by leukocyte adhesion deficiency type 1 with granulocytes transfusions , 2010, BMC dermatology.

[13]  H. Jafri,et al.  Pharmacokinetics, Safety, and Tolerability of Voriconazole in Immunocompromised Children , 2010, Antimicrobial Agents and Chemotherapy.

[14]  F. Grenouillet,et al.  International Retrospective Analysis of 73 Cases of Invasive Fusariosis Treated with Voriconazole , 2010, Antimicrobial Agents and Chemotherapy.

[15]  D. Kontoyiannis,et al.  Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009. , 2010, The Journal of infection.

[16]  R. Alaggio,et al.  Successful treatment of disseminated fusariosis in a child with acute myelogenous leukaemia with medical and surgical approach , 2010, Mycoses.

[17]  M. Hawkes,et al.  Invasive mold infections in iatrogenically immunocompromised children: An eight‐yr review , 2009, Pediatric transplantation.

[18]  M. Walsh,et al.  Cutaneous Fusarium solani infection in childhood acute lymphoblastic leukaemia , 2009, Clinical and experimental dermatology.

[19]  M. Cuenca‐Estrella,et al.  Disseminated Fusariosis Caused by Fusarium verticillioides in an Acute Lymphoblastic Leukemia Patient after Allogeneic Hematopoietic Stem Cell Transplantation , 2008, Journal of Clinical Microbiology.

[20]  Patricia Muñoz,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  E. Anaissie,et al.  Fusarium Infections in Immunocompromised Patients , 2007, Clinical Microbiology Reviews.

[22]  R. Bajo,et al.  Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report , 2007, BMC infectious diseases.

[23]  J. Lee,et al.  Treating disseminated fusariosis: amphotericin B, voriconazole or both? , 2007, Mycoses.

[24]  G. Leverger,et al.  Fusariose disséminée chez deux enfants neutropéniques , 2005 .

[25]  D. Nadal,et al.  Disseminated Fusarium oxysporum Infection in Hemophagocytic Lymphohistiocytosis , 2004, Infection.

[26]  U. Saarinen-Pihkala,et al.  Invasive fusariosis in two transplanted children , 2004, European Journal of Pediatrics.

[27]  Z. Gülay,et al.  [Case report: a Fusarium fungaemia]. , 2004, Mikrobiyoloji bulteni.

[28]  E. Adderson,et al.  Successful treatment of disseminated fusariosis , 2003, Bone Marrow Transplantation.

[29]  H. Sridhar,et al.  Fusarium solani fungemia in a patient with acute lymphoblastic leukemia. , 2001, Indian journal of cancer.

[30]  A. Di Cataldo,et al.  Successful treatment of Fusarium (spp.) infection in a child with acute lymphoblastic leukemia. , 2000, Medical and pediatric oncology.

[31]  M. Ertem,et al.  Letter to the editor: Fungal infection fromFusarium spp. in children with refractory hematologic malignancies , 1999 .

[32]  H. Ariffin,et al.  Management of systemic Fusarium infection in children with leukemia. , 1999, Medical and pediatric oncology.

[33]  B. de Camargo,et al.  Fungal infection due to Fusarium (spp) in children with refractory hematologic malignancies. , 1999, Medical and pediatric oncology.

[34]  J. Z. Neto,et al.  Disseminated Fusarium sp. infection affecting the brain of a child after bone marrow transplantation. , 1996, Bone marrow transplantation.

[35]  G. Gaedicke,et al.  A fatal infection due to Fusarium oxysporum in a child with Wilms' tumour. Case report and review of the literature , 1992, Mycoses.

[36]  A. Paller,et al.  Cutaneous Fusarium Infection in an Adolescent with Acute Leukemia , 1992, Pediatric dermatology.

[37]  C. Krill,et al.  Fusarium meningoencephalitis in a child with acute leukemia. , 1991, Neuropediatrics.

[38]  R. Summerbell,et al.  Disseminated fusarial infection in the immunocompromised host. , 1988, Reviews of infectious diseases.

[39]  R. W. Smith,et al.  Fungemia due to Fusarium solani in an immunocompromised child. , 1986, Pediatric infectious disease.

[40]  D. Snover,et al.  Invasive Fusarium infections in bone marrow transplant recipients. , 1984, The American journal of medicine.

[41]  W. Bradford,et al.  Systemic infection by fusarium in a burned child , 1974 .

[42]  C T Cho,et al.  Fusarium solani infection during treatment for acute leukemia. , 1973, The Journal of pediatrics.

[43]  M. C. Clahsen‐van Groningen,et al.  Disseminated fusariosis. , 2015, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[44]  J. Landman-Parker,et al.  [Disseminated fusarium infection in two neutropenic children]. , 2005, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[45]  M. Ertem,et al.  Fungal infection from Fusarium spp. in children with refractory hematologic malignancies. , 1999, Medical and pediatric oncology.

[46]  J. Puck,et al.  Catheter-related Fusarium solani fungemia and pulmonary infection in a patient with leukemia in remission. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  J. Humbert,et al.  Successful treatment of disseminated Fusarium infection in an immunocompromised child. , 1990, The American journal of pediatric hematology/oncology.